|Videos|July 27, 2021

Pharmaceutical CEO Leadership: Collaboration in Pharma – Greater Good

In this segment, members of the Pharmaceutical CEO Leadership: Collaboration in Pharma panel present the impact of society at large on collaborations. Brought to the forefront during COVID, a sense of purpose drove many companies to join forces in novel ways, simply with the common goal of creating solutions. The challenge now is how to keep that momentum going.

Read the full article "Capitalizing on Collaboration."


Related to this article

Former U.S. Representative Joe Cunningham (D-SC), spokesperson, Pharmaceutical Reform Alliance.
Former U.S. Representative Joe Cunningham (D-SC), spokesperson, Pharmaceutical Reform Alliance. dismisses the pharmaceutical industry's innovation argument against MFN pricing.
Joe Cunningham (D-SC) and spokesperson for the Pharmaceutical Reform Alliance,
Joe Cunningham argues that the most-favored-nation drug pricing agreements carry no legislative weight and discusses what the program actually locks in.